Does Helicobacter pylori reduce gastric acid and increase undigested substrates that fuel bacterial gas production?

Helicobacter pylori (H. pylori) infection significantly impacts the digestive environment by modulating gastric acid production and altering the efficiency of nutrient breakdown. While primarily known for its role in ulcers, its influence on upper gastrointestinal (GI) physiology has systemic effects on digestion and the gut microbiome.

Clinical and effectiveness evidence

• Acid suppression: H. pylori infection, particularly when involving the gastric corpus (pangastritis), consistently reduces gastric acid secretion. Research shows that virulence factors like the VacA toxin and the cagPAI pathogenicity island directly repress the expression of the H+/K+-ATPase (proton pump) in parietal cells.
• Impaired digestion: The resulting hypochlorhydria (low stomach acid) elevates gastric pH from a normal range of 2.3–3.5 to approximately 6.1. This shift prevents the conversion of pepsinogen into pepsin, the primary enzyme for protein digestion, leading to incomplete breakdown of dietary proteins.
• Substrate availability: Evidence shows a strong association between H. pylori and Small Intestinal Bacterial Overgrowth (SIBO), with an odds ratio of 1.82. Patients with H. pylori-related SIBO report significantly higher rates of gas-related symptoms, including bloating (OR 3.02) and flatulence (OR 4.70).

Mechanistic explanations

• Hormonal disruption: Low gastric acidity weakens the signaling pathways for secretin and cholecystokinin (CCK) in the duodenum. These hormones are critical for stimulating the pancreas to release bicarbonate and essential digestive enzymes like amylase and proteases.
• Parietal cell atrophy: Chronic infection can lead to the permanent loss of acid-secreting parietal cells in the gastric corpus, a condition known as atrophic gastritis. This creates a long-term deficit in digestive capacity.
• Microbial fermentation: When proteins and carbohydrates are not adequately broken down in the upper GI tract, they transit to the small intestine and colon as undigested substrates. This provides a metabolic niche for resident bacteria to perform fermentation, producing gases such as hydrogen, methane, and carbon dioxide.

Limitations and methodological considerations

• Anatomical variation: The impact on acid secretion depends on where the infection is concentrated. Antral-predominant gastritis may initially increase acid output due to hypergastrinemia, whereas corpus-predominant infection consistently leads to acid suppression.
• Direct substrate measurement: While the link between H. pylori, SIBO, and gas symptoms is clinically evident, there is a lack of direct metabolomic data quantifying the exact concentration of undigested substrates in the distal gut of H. pylori patients.

Bottom line

H. pylori infection reduces gastric acid secretion and impairs upper-GI digestion by inhibiting essential enzymes and hormonal signals. This increases the availability of undigested proteins and carbohydrates for bacterial fermentation, which is plausibly linked to increased gas production and symptoms like bloating.